Bridgefront Capital, LLC

Position in TLRY — Tilray Brands, Inc.

CIK 1725690 AUSTIN, TX

Position in TLRY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$227,077

+$98,106 QoQ

Shares Held

50,574

+3139.8% QoQ

Ownership

0.037%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#39

of 233 holders

Holding Since

Dec 2020

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bridgefront Capital, LLC holds $2,674,930 across 3 Drug Manufacturers - Specialty & Generic names. TLRY ranks #3 (8.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	31,649	$1,658,407
2	UTHR	UNITED THERAPEUTICS Corp	1,457	$789,446
3	TLRY	Tilray Brands, Inc. This page	50,574	$227,077

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$227,077	50,574	+223.9%	Shares	Sole	2026-08-14
2020-12-31	$128,971	15,614	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.